Our Scientific Director Dr. Peter Würtz will present two studies utilizing our technology at American Heart Association's Scientific Sessions – AHA 2016. The event features the best in science and cardiovascular clinical practice and will be held in New Orleans, November 12-16.
Metabolomic Effects of Statin Therapy, Ezetimibe and PCSK9-Inhibition: Comparison by Genetic Evidence, Nov 15, 12:30PM
Link to study
Metabolomics of Non-alcoholic Fatty Liver Disease in Young Adults Reveals Pronounced Metabolic Deviations Prior to Disease Onset, Nov 15, 4:30PM
To set up a meeting with us at AHA Scientific Sessions, please send an email to contact[at]brainshake.fi